Presentations and Publications


2020 CommNETs Publications

Click here for: Singh S, Bergsland EK, Card CM, Hope TA, Kunz PL, Laidley DT, Lawrence B, Leyden S, Metz DC, Michael M, Modahl L, Myrehaug S, Padda SK, Pommier RF, Ramirez RA, Soulen M, Strosburg J, Sung A, Thawer A, Wei B, Xu B, Segelov E. CommNETs and NANETS Guidelines for the Diagnosis and Management of Patients with Lung Neuroendocrine Tumors: An International Collaborative Endorsement and Update of the 2015 ENETS Expert Consensus Guidelines. (2020). Journal of Thoracic Oncology, 15(10), DOI: 10.1016/j.jtho.2020.06.021

Click here for: Choi, J., Koea, J.B. (2020). Why are there so few surgical trials in neuroendocrine tumours? ANZ Journal of Surgery. doi: 10.1111/ans.15798

Click here for: Gordon, L.G., Elliott, T.M., Wakelin, K., Leyden, S., Leyden, J., Michael, M., Pavlakis, P., Mumford, J., Segelov E., Wyld, D.K. (2020). The Economic Impact on Australian Patients with Neuroendocrine Tumours. The Patient – Patient-Centered Outcomes Research

 


2019 CommNETs Publications

Click here for: Woodhouse B., Pattison S., Segelov E., Singh S., Parker K., Kong G., Macdonald W., Wyld D., Meyer-Rochow G., Pavlakis N., Conroy S., Gordon V., Koea J., Kramer N., Michael M., Wakelin K., Asif T., Lo D., Price T., Lawrence B. (2019). Consensus-Derived Quality Performance Indicators for Neuroendocrine Tumour Care. Journal of Clinical Medicine, 8(9), 1455.

Click here for: Aramoana J., Koea J. (2019). An Integrative Review of the Barriers to Indigenous Peoples Participation in Biobanking and Genomic Research.  J of Global Oncology 2018; Published online 7 March 2019. DOI: 10.1200/JGO.18.00156


2018 CommNETs Publications

Click here for: Chan D.L., Moody L., Segelov E., Metz D., Strosberg J., Pavlakis N., Singh S. (2018). “Follow-up for resected gastroenteropancreatic neuroendocrine tumours (GEP-NETs): A practice survey of the Commonwealth Neuroendocrine collaboration (CommNETs) and the North American Neuroendocrine Tumor Society (NANETS).” Neuroendocrinology (accepted for publication), doi:10.1159/000488394.

Click here for: Singh S., Moody L., Chan D.L. Metz D., Strosberg J., Asmis T., Bailey D., Bergsland E., Brendtro K., Carroll R., Cleary S., Kim M., Kong G., Law C., Lawrence B., McEwan S., McGregor C., Michael M., Pasieka J., Pavlakis N., Pommier R., Soulen M., Wyld D., Segelov E. (2018) “Follow-up Recommendations for Completely Resected Gastroenteropancreatic Neuroendocrine Tumours.” JAMA Oncology, doi: doi:10.1001/jamaoncol.2018.2428.

Click here for: Singh S, Chan DL, Moody L, Liu N, Fischer HD, Austin PC, Segelov E. 2018. Recurrence in Resected Gastroenteropancreatic Neuroendocrine Tumors. JAMA Oncology. 4:583-585. Impact factor 16.


2017 CommNETs Publications

Click here for: Segelov, E., Chan, D., Lawrence, B., Pavlakis, N., Kennecke, H. F., Jackson, C., et al. (2017). Identifying and Prioritizing Gaps in Neuroendocrine Tumor Research: A Modified Delphi Process With Patients and Health Care Providers to Set the Research Action Plan for the Newly Formed Commonwealth Neuroendocrine Tumor Collaboration., 3(4), 380–388.


CommNETs Members’ NET Publications

Click here for: Segelov, E. (2020). Advances in Diagnosis and Therapy of Neuroendocrine Neoplasms [Special issue]. Journal of Clinical Medicine.

Click here for: Wyld, D., Wan, M.H., Moore, J., Dunn, N., Youl, P. (2019). Epidemiological trends of neuroendocrine tumours over three decades in Queensland, Australia. Cancer Epidemiology, Volume 63.

To view  past CommNETs Members Publications please click here


2020 Presentations

ENETS  2020 VIRTUAL CONFERENCE

Click here for: Economic Impact Australian NETs_ENETS 2020 The economic impact to Australian patients with neuroendocrine tumours’.

Click here for:  Shared Care Model_ENETS 2020 Insights into the Practice Patterns, Challenges and the Role of a Shared Care Model in the Management of NET Patients in the Community.

 


2019 Presentations

NANETS ANNUAL MULTIDISCIPLINARY NET MEDICAL SYMPOSIUM, OCTOBER 3rd – 5th 2019, BOSTON MA

Click here for: Understanding the Treatment Preferences of NET Patients Using Discrete Choice Experiments.


2018 Presentations

ANNUAL APNETS MEETING, NOVEMBER 9th – 11th 2018, MELBOURNE, VIC, AUSTRALIA

Click here for: Neuroendocrine neoplasms in the paediatric adolescent and young adult population in New Zealand and Queensland Australia.

INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER WORLD CONFERENCE ON LUNG CANCER, SEPTEMBER 23RD -26TH TORONTO, ON, CAN

Click here for: Pulmonary Neuroendocrine (Carcinoid) Tumors: CommNETs/NANETS Endorsement and Update of the ENETs Best Practice Consensus.

NANETs SYMPOSIUM, OCTOBER 4TH-6TH SEATTLE, WA, USA

Click here for: Ontario oncologists’ perspective on addressing potential barriers in the management of patients with neuroendocrine tumors.

Click here for: Practice Patterns, Challenges and the Role of a Shared Care Model in the Management of Neuroendocrine (NET) Patients.

ESMO 2018 CONGRESS OCTOBER 19TH – 23RD 2018, MUNICH GERMANY

Click here for: The commonwealth neuroendocrine tumour collaboration (CommNETs) and North American neuroendocrine tumor society (NANETS) endorsement and update of European neuroendocrine tumor society (ENETS) best practice consensus for lung neuroendocrine tumors (LNET).

VCCC Survivorship Conference February 8th – 9th | Melbourne, VIC, Australia

Poster Presented by Commonwealth Neuroendocrine Tumour Collaboration (CommNETS) PRRT Working Group.

The challenges of designing and implementing a structured, international multicentre audit on quality of life (QOL) and markers of response in patients with neuroendocrine neoplasms (NEN) treated with peptide receptor radionuclide therapy (PRRT). Poster presented: Click here


Past Presentations

To view all past CommNETs presentations and NETs presentations  please click here

Share